These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 33052796)

  • 1. Impact of wound duration on diabetic foot ulcer healing: evaluation of a new sucrose octasulfate wound dressing.
    Lobmann R; Grünerbel A; Lawall H; Lüdemann C; Morbach S; Tigges W; Völkel L; Rychlik RP
    J Wound Care; 2020 Oct; 29(10):543-551. PubMed ID: 33052796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of TLC-sucrose octasulfate versus control dressings in the treatment of diabetic foot ulcers.
    Lobmann R; Augustin M; Lawall H; Tigges W; Potempa C; Thiem H; Fietz C; Rychlik RP
    J Wound Care; 2019 Dec; 28(12):808-816. PubMed ID: 31825772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial.
    Edmonds M; Lázaro-Martínez JL; Alfayate-García JM; Martini J; Petit JM; Rayman G; Lobmann R; Uccioli L; Sauvadet A; Bohbot S; Kerihuel JC; Piaggesi A
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):186-196. PubMed ID: 29275068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal wound closure of diabetic foot ulcers with early initiation of TLC-NOSF treatment: post-hoc analysis of Explorer.
    Lázaro-Martínez JL; Edmonds M; Rayman G; Apelqvist J; Van Acker K; Hartemann A; Martini J; Lobmann R; Bohbot S; Kerihuel JC; Piaggesi A
    J Wound Care; 2019 Jun; 28(6):358-367. PubMed ID: 31166858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sucrose Octasulfate-Impregnated Dressings for Adults With Difficult-to-Heal Noninfected Diabetic Foot Ulcers and Difficult-to-Heal Noninfected Venous Leg Ulcers: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2024; 24(4):1-101. PubMed ID: 39070301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic Evaluation of Sucrose Octasulfate Dressing for Treatment of Diabetic Foot Ulcers in Patients with Type 2 Diabetes.
    Wen J; Jin X; Al Sayah F; Johnson JA; Paulden M; Ohinmaa A
    Can J Diabetes; 2022 Mar; 46(2):126-133. PubMed ID: 35148951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of sucrose octasulfate (TLC-NOSF) dressings in the treatment of chronic wounds: a systematic review.
    Nair H; Venkateshwaran N; Seetharaman S S; Deng W; Uthaipaisanwong A; Galea E
    J Wound Care; 2021 Apr; 30(Sup4):S42-S52. PubMed ID: 33856929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing Transcutaneous Oxygen Pressure in Patients With Neuroischemic Diabetic Foot Ulcers Treated With a Sucrose Octasulfate Dressing: A Pilot Study.
    Lázaro-Martínez JL; García-Madrid M; García-Alamino JM; Bohbot S; García-Klepzig JL; García-Álvarez Y
    Int J Low Extrem Wounds; 2022 Dec; 21(4):450-456. PubMed ID: 32856522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sucrose octasulfate-evidence in the treatment of chronic wounds].
    Dissemond J; Augustin M; Dietlein M; Keuthage W; Läuchli S; Lobmann R; Münter KC; Stücker M; Traber J; Vanscheidt W; Strohal R
    Hautarzt; 2020 Oct; 71(10):791-801. PubMed ID: 32638031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alginate dressings for healing diabetic foot ulcers.
    Dumville JC; O'Meara S; Deshpande S; Speak K
    Cochrane Database Syst Rev; 2012 Feb; (2):CD009110. PubMed ID: 22336860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of TLC-NOSF dressings versus neutral dressings for the treatment of diabetic foot ulcers in France.
    Maunoury F; Oury A; Fortin S; Thomassin L; Bohbot S;
    PLoS One; 2021; 16(1):e0245652. PubMed ID: 33481840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a collagen matrix dressing on a neuropathic diabetic foot ulcer: a randomised control trial.
    Djavid GE; Tabaie SM; Tajali SB; Totounchi M; Farhoud A; Fateh M; Ghafghazi M; Koosha M; Taghizadeh S
    J Wound Care; 2020 Mar; 29(Sup3):S13-S18. PubMed ID: 32160125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Sucrose Octasulfate Dressing in the Treatment of Neuro-Ischaemic Diabetic Foot Heel Ulcers: A Retrospective Single arm Study.
    Meloni M; Giurato L; Panunzi A; Bellia A; Bohbot S; Lauro D; Uccioli L
    Int J Low Extrem Wounds; 2022 Mar; ():15347346221087499. PubMed ID: 35287510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled trial of the use of three dressing preparations in the management of chronic ulceration of the foot in diabetes.
    Jeffcoate WJ; Price PE; Phillips CJ; Game FL; Mudge E; Davies S; Amery CM; Edmonds ME; Gibby OM; Johnson AB; Jones GR; Masson E; Patmore JE; Price D; Rayman G; Harding KG
    Health Technol Assess; 2009 Nov; 13(54):1-86, iii-iv. PubMed ID: 19922726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid dressing (Healoderm) in the treatment of diabetic foot ulcer: A prospective, randomized, placebo-controlled, single-center study.
    Lee M; Han SH; Choi WJ; Chung KH; Lee JW
    Wound Repair Regen; 2016 May; 24(3):581-8. PubMed ID: 26972358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of silver dressings in the treatment of diabetic foot ulcers: a systematic review and meta-analysis.
    Luo Y; Li L; Zhao P; Yang C; Zhang J
    J Wound Care; 2022 Nov; 31(11):979-986. PubMed ID: 36367799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers.
    Veves A; Sheehan P; Pham HT
    Arch Surg; 2002 Jul; 137(7):822-7. PubMed ID: 12093340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomised placebo-controlled trial assessing the efficacy of silver dressings to enhance healing of acute diabetes-related foot ulcers.
    Lafontaine N; Jolley J; Kyi M; King S; Iacobaccio L; Staunton E; Wilson B; Seymour C; Rogasch S; Wraight P
    Diabetologia; 2023 Apr; 66(4):768-776. PubMed ID: 36629877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success.
    Saco M; Howe N; Nathoo R; Cherpelis B
    Dermatol Online J; 2016 Aug; 22(8):. PubMed ID: 27617934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products.
    Gilligan AM; Waycaster CR; Landsman AL
    J Wound Care; 2015 Mar; 24(3):149-56. PubMed ID: 25764960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.